Preferred Label : dihematoporphyrin ether;

MeSH definition : The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.;

MeSH synonym : porfimer; ether, dihematoporphyrin; dihematoporphyrin ester; dhp ether;

MeSH hyponym : photofrin; Porfimer Sodium; photofrin II;

MeSH CAS label : 21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-;

MeSH Related Number : porfimer sodium; 87806-31-3 (porfimer sodium);

Registry Number MeSH : 97067-70-4;

Related CAS MeSH : 87806-31-3 (Porfimer sodium);

Wikipedia link : https://en.wikipedia.org/wiki/Photofrin;

Is substance : O;

Details


Main resources

You can consult :

The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.

http://www.has-sante.fr/portail/jcms/c_1758559/fr/photofrin
2014
false
false
false
France
French
evaluation of the transparency committee
Porfimer Sodium
carcinoma, non-small-cell lung
neoplasm recurrence, local
esophageal neoplasms
injections, intravenous
treatment outcome
porfimer sodium
antineoplastic agents
photosensitizing agents
photochemotherapy
continuity of patient care
dihematoporphyrin ether

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65810660
2012
France
summary of product characteristics
package leaflet
powders
injections
dihematoporphyrin ether

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67956379
2012
France
summary of product characteristics
package leaflet
injections
powders
dihematoporphyrin ether

---
https://www.ema.europa.eu/medicines/human/EPAR/PhotoBarr
2009
United Kingdom
French
English
syndication feed
Contraindications, Procedure
orphan drug production
dihematoporphyrin ether
antineoplastic agents
photosensitizing agents
barrett esophagus
antineoplastic agents
photosensitizing agents
dihematoporphyrin ether
treatment outcome
injections, intravenous
adult
aged
dihematoporphyrin ether
antineoplastic agents
photosensitizing agents
drug interactions
pregnancy
breast feeding
dihematoporphyrin ether
photosensitizing agents
antineoplastic agents
drug compounding
drug approval
drug labeling
porfimer sodium
hematoporphyrin photoradiation
precancerous conditions
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug

---
http://www.has-sante.fr/portail/display.jsp?id=c_245379
2004
France
French
dihematoporphyrin ether
photosensitizing agents
antineoplastic agents
porfimer sodium
orphan drug production
photochemotherapy
precancerous conditions
barrett esophagus
guidelines for drug use

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-de-la-therapie-photodynamique-au-porfimer-sodique-des-cancers-de-loesophage-de-la-vessie-et-du-poumon.html
2004
false
Canada
French
technical report
health technology assessment
table
figure
comparative study
bibliography of medicine
esophageal neoplasms
lung neoplasms
urinary bladder neoplasms
dihematoporphyrin ether
esophageal neoplasms
urinary bladder neoplasms
lung neoplasms
barrett esophagus
photochemotherapy
canada
dihematoporphyrin ether
photochemotherapy
esophageal neoplasms
quebec
incidence
esophageal neoplasms
sex distribution
lung neoplasms
lung neoplasms
urinary bladder neoplasms
urinary bladder neoplasms
treatment outcome
photochemotherapy
neoplasm staging
france
united states
palliative care
photochemotherapy
costs and cost analysis
Cost-Benefit analysis
prostheses and implants
randomized controlled trials as topic
Evidence-Based medicine
ophthalmoscopy

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.